Remko van Leeuwen

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Treatment And Prevention, Medicine, First-line Antiretroviral Therapy +9

Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

Rob Schuurman, Monique Nijhuis, Remko van Leeuwen et al. · The Journal of Infectious Diseases · 1995 · 517 citations

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

Marieke den Brinker, Ferdinand W.N.M. Wit, Pauline M. E. Wertheim-van Dillen et al. · AIDS · 2000 · 396 citations

Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy

Norbert A. Foudraine, Gerrit Jan Weverling, Tom van Gool et al. · AIDS · 1998 · 194 citations

Pharmacokinetics and Antiretroviral Activity of Lamivudine Alone or When Coadministered with Zidovudine in Human Immunodeficiency Virus Type 1–Infected Pregnant Women and Their Offspring

Jagidesa Moodley, Dhayendre Moodley, Kubendran Pillay et al. · The Journal of Infectious Diseases · 1998 · 189 citations · Full text

Drug Interactions, Hiv-1 Rna, Antiretroviral Activity +13